Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel piperine-carboximidamide hybrids: design, synthesis, and antiproliferative activity via a multi-targeted inhibitory pathway
Lamya H. Al-Wahaibi, Mohamed A. Mahmoud, Yaser A. Mostafa, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 38, Iss. 1, pp. 376-386
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Design, synthesis, and antiproliferative properties of new 1,2,3-triazole-carboximidamide derivatives as dual EGFR/VEGFR-2 inhibitors
Mohamed A. Mahmoud, Anber F. Mohammed, Ola I. A. Salem, et al.
Journal of Molecular Structure (2023) Vol. 1282, pp. 135165-135165
Closed Access | Times Cited: 25
Design, synthesis, and apoptotic antiproliferative action of new 1,2,3-triazole/1,2,4-oxadiazole hybrids as dual EGFR/VEGFR-2 inhibitors
Mohamed A. Mahmoud, Anber F. Mohammed, Ola I. A. Salem, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 11
Design and Synthesis of New Dihydropyrimidine Derivatives with a Cytotoxic Effect as Dual EGFR/VEGFR-2 Inhibitors
Lamya H. Al-Wahaibi, Ali M. Elshamsy, Taha F. S. Ali, et al.
ACS Omega (2024) Vol. 9, Iss. 32, pp. 34358-34369
Open Access | Times Cited: 11
Benzimidazole-Based Derivatives as Apoptotic Antiproliferative Agents: Design, Synthesis, Docking, and Mechanistic Studies
Bahaa G. M. Youssif, Martha M. Morcoss, Stefan Bräse, et al.
Molecules (2024) Vol. 29, Iss. 2, pp. 446-446
Open Access | Times Cited: 9
Design, Synthesis, and Antiproliferative Activity of New 5-Chloro-indole-2-carboxylate and Pyrrolo[3,4-b]indol-3-one Derivatives as Potent Inhibitors of EGFRT790M/BRAFV600E Pathways
Lamya H. Al-Wahaibi, Anber F. Mohammed, Mostafa Abdelrahman, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1269-1269
Open Access | Times Cited: 15
Piperine: an emerging biofactor with anticancer efficacy and therapeutic potential
Hesti Lina Wiraswati, Ilma Fauziah Ma’ruf, Javad Sharifi‐Rad, et al.
BioFactors (2024)
Closed Access | Times Cited: 5
An updated literature on BRAF inhibitors (2018–2023)
Lalmohan Maji, Ghanshyam Teli, Nulgumnalli Manjunathaiah Raghavendra, et al.
Molecular Diversity (2023) Vol. 28, Iss. 4, pp. 2689-2730
Closed Access | Times Cited: 12
Design and synthesis of new 1,2,4-oxadiazole/quinazoline-4-one hybrids with antiproliferative activity as multitargeted inhibitors
Amira M. Mohamed, Ola M. F. Abou‐Ghadir, Yaser A. Mostafa, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 4
Design, synthesis, and apoptotic antiproliferative action of new benzimidazole/1,2,3-triazole hybrids as EGFR inhibitors
Abubakar Ahmed, Anber F. Mohammed, Zainab M. Almarhoon, et al.
Frontiers in Chemistry (2025) Vol. 12
Open Access
Design, synthesis, antiproliferative activity, and molecular dynamics simulation of pyrazoline-based derivatives as dual EGFR and HER-2 inhibitors
Hani M. Hafez, Basmat Amal M. Said, Ahmed M. Sayed, et al.
RSC Advances (2025) Vol. 15, Iss. 12, pp. 9265-9279
Open Access
Design, Synthesis, and Computational Studies of Novel Pyrazoline-Based Dual EGFR/HER2 Inhibitors with Apoptotic Antiproliferative Activity
Lamya H. Al-Wahaibi, Hani M. Hafez, Fadwa H. Edrees, et al.
Journal of Molecular Structure (2025), pp. 142364-142364
Closed Access
Design, synthesis, in silico studies, and apoptotic antiproliferative activity of novel thiazole-2-acetamide derivatives as tubulin polymerization inhibitors
Lamya H. Al-Wahaibi, Ali M. Elshamsy, Taha F. S. Ali, et al.
Frontiers in Chemistry (2025) Vol. 13
Open Access
Design, Synthesis, and Biological Evaluation of Novel 3-Cyanopyridone/Pyrazoline Hybrids as Potential Apoptotic Antiproliferative Agents Targeting EGFR/BRAFV600E Inhibitory Pathways
Lamya H. Al-Wahaibi, Hesham A. Abou‐Zied, Mohamed Hisham, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6586-6586
Open Access | Times Cited: 10
Synthesis and Structure Determination of Substituted Thiazole Derivatives as EGFR/BRAFV600E Dual Inhibitors Endowed with Antiproliferative Activity
Lamya H. Al-Wahaibi, Essmat M. El‐Sheref, Alaa A. Hassan, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 1014-1014
Open Access | Times Cited: 9
Synthesis of a new series of 4-pyrazolylquinolinones with apoptotic antiproliferative effects as dual EGFR/BRAFV600E inhibitors
Lamya H. Al-Wahaibi, Bahaa G. M. Youssif, Hesham A. Abou‐Zied, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 7, pp. 2538-2552
Closed Access | Times Cited: 3
Design and synthesis of new quinoline-ester/-amide derivatives as potent antiproliferative agent targeting EGFR and BRAFV600E kinases
Aliaa M. Mohassab, Heba A. Hassan, Hesham A. Abou‐Zied, et al.
Journal of Molecular Structure (2023) Vol. 1297, pp. 136953-136953
Closed Access | Times Cited: 7
New Pyrazole/Pyrimidine-Based Scaffolds as Inhibitors of Heat Shock Protein 90 Endowed with Apoptotic Anti-Breast Cancer Activity
Lamya H. Al-Wahaibi, Mohammed A. I. Elbastawesy, Nader E. Abo‐Dya, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1284-1284
Open Access | Times Cited: 2
Design, synthesis, and biological evaluation of novel quinoline-based EGFR/HER-2 dual-target inhibitors as potential anti-tumor agents
Lamya H. Al-Wahaibi, Essmat M. El‐Sheref, Hendawy N. Tawfeek, et al.
RSC Advances (2024) Vol. 14, Iss. 45, pp. 32978-32991
Open Access | Times Cited: 2
Design, Synthesis, and Biological Evaluation of Indole-2-carboxamides as Potential Multi-Target Antiproliferative Agents
Lamya H. Al-Wahaibi, Anber F. Mohammed, Mostafa Abdelrahman, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 1039-1039
Open Access | Times Cited: 6
Synthesis, Antioxidant and Antiproliferative Actions of 4-(1,2,3-Triazol-1-yl)quinolin-2(1H)-ones as Multi-Target Inhibitors
Essmat M. El‐Sheref, Stefan Bräse, Hendawy N. Tawfeek, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13300-13300
Open Access | Times Cited: 6
Pan-Cancer Analysis of the LOX Family Reveals that LOX Affects Tumor Prognosis by Affecting Immune Infiltration
Chunlong Zheng, Yan Chu, Nian Zhang, et al.
Critical Reviews in Eukaryotic Gene Expression (2023) Vol. 34, Iss. 2, pp. 87-100
Closed Access | Times Cited: 3
Design, synthesis, and biological evaluation of indole-2-carboxamides as SARS CoV-2 main protease inhibitors
Hesham A. M. Gomaa, Mohamed E. Shaker, Sami I. Alzarea, et al.
Tetrahedron (2023) Vol. 146, pp. 133628-133628
Closed Access | Times Cited: 2
GC-MS profiling and evaluation of acute oral toxicity, anti-tumour, antimicrobial and antioxidant activities of Croton socotranus Balf.f. aerial parts: in-vitro , in-vivo and in-silico studies
Ibrahim Ali Al-Hakami, Amina El‐Shaibany, Hassan Al‐Mahbashi, et al.
Natural Product Research (2023) Vol. 38, Iss. 24, pp. 4307-4316
Closed Access | Times Cited: 2
Synthesis and Antiproliferative Potential of Thiazole and 4-Thiazolidinone Containing Motifs as Dual Inhibitors of EGFR and BRAFV600E
Alaa A. Hassan, Nasr K. Mohamed, Ashraf A. Aly, et al.
Molecules (2023) Vol. 28, Iss. 24, pp. 7951-7951
Open Access | Times Cited: 2
New pyrrolidine‐carboxamide derivatives as dual antiproliferative EGFR/CDK2 inhibitors
Frias Obaid Arhema Frejat, Bing Zhao, Nooruldeen Furaijit, et al.
Chemical Biology & Drug Design (2023) Vol. 103, Iss. 1
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top